Exp Ther Med. 2022 Jan;23(1):6. doi: 10.3892/etm.2021.10928. Epub 2021 Oct 27.
Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data.
Experimental and therapeutic medicine
Fan Liang, Le Peng, Yong-Gang Ma, Wei Hu, Wei-Bing Zhang, Ming Deng, Ya-Ming Li
Affiliations
Affiliations
- Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
PMID: 34815758
PMCID: PMC8593859 DOI: 10.3892/etm.2021.10928
Abstract
Osteoarthritis (OA) is the most prevalent chronic degenerative disease that affects the health of the elderly. The present study aimed to identify significant genes involved in OA via bioinformatics analysis. A gene expression dataset (GSE104793) was downloaded from the Gene Expression Omnibus. Bioinformatics analysis was then performed in order to identify differentially expressed genes (DEGs) between untreated chondrocytes and chondrocytes cultured with interleukin-1β (IL-1β) for 24 h. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using Metascape. A protein-protein interaction network of DEGs was constructed using the Search Tool for the Retrieval of Interacting Genes. Gene set enrichment analysis (GSEA) was performed using GSEA software. Furthermore, chondrocytes were extracted and treated with IL-1β (10 ng/ml) for 24 h, and reverse-transcription quantitative PCR was used to confirm differential expression of hub genes. Patient samples were also collected to verify the bioinformatic analysis results. Based on the cut-off criteria used for determination of the DEGs, a total of 844 DEGs, including 498 upregulated and 346 downregulated DEGs, were identified. The DEGs were mainly enriched in the GO terms and KEGG pathways 'inflammatory response', 'negative regulation of cell proliferation', 'ossification', 'taxis', 'blood vessel morphogenesis', 'extracellular structure organization', 'mitotic cell cycle process' and 'TNF signaling pathway'. The majority of the PCR results, namely the differential expression of kininogen 2, complement C3, cyclin B1, cell division cycle 20, cyclin A2, 1-phosphatidylinositol 4-kinase, BUB1 mitotic checkpoint serine/threonine kinase, kinesin family member 11, cyclin B2 and BUB1 mitotic checkpoint serine/threonine kinase B were consistent with the bioinformatics results. Collectively, the present observations provided a regulation network of IL-1β-stimulated chondrocytes, which may provide potential targets of OA therapy.
Copyright: © Liang et al.
Keywords: bioinformatics analysis; differentially expressed genes; osteoarthritis
Conflict of interest statement
The authors declare that they have no competing interests.
References
- Nat Commun. 2020 May 1;11(1):2132 - PubMed
- Chem Biol Interact. 2018 Apr 25;286:45-51 - PubMed
- Br J Nutr. 2013 Jul 28;110(2):241-55 - PubMed
- Oncol Lett. 2020 Aug;20(2):1695-1708 - PubMed
- J Mol Cell Cardiol. 2020 Aug;145:1-13 - PubMed
- Arthritis Rheum. 2000 Jan;43(1):215-25 - PubMed
- Biochemistry. 2004 Apr 27;43(16):4791-8 - PubMed
- Osteoarthritis Cartilage. 2020 Sep;28(9):1154-1169 - PubMed
- Inflammation. 2020 Oct;43(5):1742-1750 - PubMed
- Sci Rep. 2020 May 20;10(1):8372 - PubMed
- BMC Musculoskelet Disord. 2020 May 29;21(1):332 - PubMed
- Arthroscopy. 2020 May;36(5):1452-1464.e2 - PubMed
- Pain Res Manag. 2020 Mar 10;2020:7587936 - PubMed
- Drug Des Devel Ther. 2020 Mar 26;14:1227-1240 - PubMed
- Vet J. 2016 Mar;209:40-9 - PubMed
- Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1875-80 - PubMed
- JAMA. 2018 Dec 25;320(24):2564-2579 - PubMed
- Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6698-703 - PubMed
- Mol Med Rep. 2015 Oct;12(4):5211-6 - PubMed
- Drugs Aging. 2019 Apr;36(Suppl 1):45-64 - PubMed
- Inflamm Res. 2020 Jun;69(6):619-630 - PubMed
- Exp Ther Med. 2019 Sep;18(3):2079-2085 - PubMed
- Transl Lung Cancer Res. 2020 Apr;9(2):218-231 - PubMed
- Sci Rep. 2020 May 5;10(1):7558 - PubMed
- Exp Ther Med. 2019 Apr;17(4):2614-2622 - PubMed
- Sci Rep. 2019 Dec 19;9(1):19437 - PubMed
- Oncol Lett. 2020 Oct;20(4):60 - PubMed
- J Hazard Mater. 2021 Sep 5;417:125997 - PubMed
- J Int Med Res. 2020 Jul;48(7):300060520910019 - PubMed
- Nat Commun. 2019 Apr 3;10(1):1523 - PubMed
- J Exp Med. 2005 May 2;201(9):1355-9 - PubMed
- Methods Mol Biol. 2011;696:291-303 - PubMed
- Drug Des Devel Ther. 2020 Jul 07;14:2645-2655 - PubMed
- Biochem Biophys Res Commun. 2020 Jun 25;527(2):458-465 - PubMed
- Int Immunopharmacol. 2020 Aug;85:106612 - PubMed
- J Orthop Translat. 2019 Aug 06;22:14-25 - PubMed
- Exp Cell Res. 2018 May 15;366(2):81-91 - PubMed
- Yonsei Med J. 2018 Aug;59(6):760-768 - PubMed
Publication Types